Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Puripharm (Huzhou Purui Biopharmaceutical Technology) is a high-tech biopharmaceutical company specializing in the development and commercialization of functional bioactive ingredients and advanced drug delivery systems. Founded in 2015 by a team of experts with extensive experience in nanomedicine, the company focuses on overcoming challenges related to the solubility, stability, and bioavailability of active compounds. Puripharm utilizes proprietary technology platforms, including its Nano-Delivery System (NDS), Smart Gel System, and Transdermal Delivery System, to produce high-performance ingredients for the cosmetic, pharmaceutical, and functional food industries. Its product portfolio features nano-encapsulated retinoids, antioxidants, and anti-inflammatory agents, such as NanoActive Retinal and NanoActive CBD. Additionally, the company provides custom formulation services and R&D support for the development of innovative nanomedicines and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huzhou Purui Biopharmaceutical Technology.